Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 44% ± 15% | |
lung | 17 studies | 50% ± 12% | |
intestine | 13 studies | 46% ± 22% | |
brain | 10 studies | 30% ± 11% | |
kidney | 9 studies | 42% ± 13% | |
eye | 9 studies | 32% ± 19% | |
liver | 8 studies | 35% ± 12% | |
bone marrow | 6 studies | 42% ± 16% | |
uterus | 6 studies | 60% ± 14% | |
lymph node | 6 studies | 45% ± 12% | |
pancreas | 5 studies | 63% ± 21% | |
placenta | 4 studies | 67% ± 26% | |
prostate | 4 studies | 52% ± 10% | |
skin | 4 studies | 36% ± 6% | |
breast | 4 studies | 51% ± 7% | |
ovary | 3 studies | 51% ± 4% | |
heart | 3 studies | 27% ± 8% | |
adrenal gland | 3 studies | 42% ± 14% | |
esophagus | 3 studies | 40% ± 22% | |
thymus | 3 studies | 49% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 25827.86 | 328 / 328 | 100% | 591.04 | 178 / 178 |
ovary | 100% | 23612.69 | 180 / 180 | 100% | 426.19 | 429 / 430 |
thymus | 100% | 55302.75 | 653 / 653 | 100% | 1016.51 | 603 / 605 |
uterus | 100% | 20631.23 | 170 / 170 | 100% | 702.78 | 457 / 459 |
lung | 99% | 35184.93 | 575 / 578 | 100% | 755.69 | 1155 / 1155 |
intestine | 100% | 20719.18 | 962 / 966 | 100% | 618.73 | 525 / 527 |
bladder | 100% | 24668.62 | 21 / 21 | 99% | 594.16 | 500 / 504 |
breast | 100% | 28979.54 | 459 / 459 | 99% | 749.92 | 1108 / 1118 |
stomach | 99% | 22359.44 | 355 / 359 | 100% | 540.22 | 286 / 286 |
esophagus | 99% | 17820.10 | 1427 / 1445 | 100% | 642.40 | 183 / 183 |
prostate | 99% | 17910.46 | 242 / 245 | 99% | 771.83 | 498 / 502 |
skin | 99% | 37806.48 | 1789 / 1809 | 98% | 670.70 | 464 / 472 |
kidney | 100% | 28167.22 | 89 / 89 | 97% | 458.98 | 874 / 901 |
adrenal gland | 99% | 26206.75 | 256 / 258 | 94% | 593.56 | 216 / 230 |
liver | 93% | 34892.80 | 211 / 226 | 100% | 667.41 | 405 / 406 |
brain | 85% | 11407.14 | 2249 / 2642 | 100% | 394.52 | 703 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 532.05 | 29 / 29 |
spleen | 100% | 23911.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 594.30 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 221.38 | 1 / 1 |
adipose | 100% | 29486.38 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 32841.79 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 31719.41 | 810 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 29949.90 | 868 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 274.46 | 72 / 80 |
muscle | 80% | 8721.19 | 645 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903894 | Biological process | regulation of IRE1-mediated unfolded protein response |
GO_0042149 | Biological process | cellular response to glucose starvation |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0060904 | Biological process | regulation of protein folding in endoplasmic reticulum |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_1903895 | Biological process | negative regulation of IRE1-mediated unfolded protein response |
GO_0031333 | Biological process | negative regulation of protein-containing complex assembly |
GO_0006983 | Biological process | ER overload response |
GO_1903897 | Biological process | regulation of PERK-mediated unfolded protein response |
GO_0031204 | Biological process | post-translational protein targeting to membrane, translocation |
GO_0071353 | Biological process | cellular response to interleukin-4 |
GO_0021680 | Biological process | cerebellar Purkinje cell layer development |
GO_1903891 | Biological process | regulation of ATF6-mediated unfolded protein response |
GO_0021589 | Biological process | cerebellum structural organization |
GO_0030968 | Biological process | endoplasmic reticulum unfolded protein response |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0034975 | Biological process | protein folding in endoplasmic reticulum |
GO_0042026 | Biological process | protein refolding |
GO_0021762 | Biological process | substantia nigra development |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0035437 | Biological process | maintenance of protein localization in endoplasmic reticulum |
GO_0051085 | Biological process | chaperone cofactor-dependent protein refolding |
GO_0036503 | Biological process | ERAD pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0030496 | Cellular component | midbody |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005925 | Cellular component | focal adhesion |
GO_0009986 | Cellular component | cell surface |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0008180 | Cellular component | COP9 signalosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
GO_0034663 | Cellular component | endoplasmic reticulum chaperone complex |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0042470 | Cellular component | melanosome |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0051787 | Molecular function | misfolded protein binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0044183 | Molecular function | protein folding chaperone |
GO_0043022 | Molecular function | ribosome binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0031072 | Molecular function | heat shock protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0051087 | Molecular function | protein-folding chaperone binding |
GO_0140662 | Molecular function | ATP-dependent protein folding chaperone |
GO_0005524 | Molecular function | ATP binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | HSPA5 |
Protein name | 78 kDa glucose-regulated protein (Binding-immunoglobulin protein) (Heat shock protein 70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein) Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein) |
Synonyms | GRP78 |
Description | FUNCTION: Endoplasmic reticulum chaperone that plays a key role in protein folding and quality control in the endoplasmic reticulum lumen . Involved in the correct folding of proteins and degradation of misfolded proteins via its interaction with DNAJC10/ERdj5, probably to facilitate the release of DNAJC10/ERdj5 from its substrate (By similarity). Acts as a key repressor of the ERN1/IRE1-mediated unfolded protein response (UPR) . In the unstressed endoplasmic reticulum, recruited by DNAJB9/ERdj4 to the luminal region of ERN1/IRE1, leading to disrupt the dimerization of ERN1/IRE1, thereby inactivating ERN1/IRE1 (By similarity). Accumulation of misfolded protein in the endoplasmic reticulum causes release of HSPA5/BiP from ERN1/IRE1, allowing homodimerization and subsequent activation of ERN1/IRE1 (By similarity). Plays an auxiliary role in post-translational transport of small presecretory proteins across endoplasmic reticulum (ER). May function as an allosteric modulator for SEC61 channel-forming translocon complex, likely cooperating with SEC62 to enable the productive insertion of these precursors into SEC61 channel. Appears to specifically regulate translocation of precursors having inhibitory residues in their mature region that weaken channel gating. May also play a role in apoptosis and cell proliferation . .; FUNCTION: (Microbial infection) Plays an important role in viral binding to the host cell membrane and entry for several flaviruses such as Dengue virus, Zika virus and Japanese encephalitis virus . Acts as a component of the cellular receptor for Dengue virus serotype 2/DENV-2 on human liver cells . .; FUNCTION: (Microbial infection) Acts as a receptor for CotH proteins expressed by fungi of the order mucorales, the causative agent of mucormycosis, which plays an important role in epithelial cell invasion by the fungi . Acts as a receptor for R.delemar CotH3 in nasal epithelial cells, which may be an early step in rhinoorbital/cerebral mucormycosis (RCM) disease progression . . |
Accessions | ENST00000680272.1 A0A7P0TAI0 P11021 ENST00000680032.1 ENST00000324460.7 A0A7P0TB36 |